Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Filippo de Marinis"'
Autor:
Sai-Hong Ignatius, Ou, Makoto, Nishio, Myung-Ju, Ahn, Tony, Mok, Fabrice, Barlesi, Caicun, Zhou, Enriqueta, Felip, Filippo, de Marinis, Sang-We, Kim, Maurice, Pérol, Geoffrey, Liu, Maria Rita, Migliorino, Dong-Wan, Kim, Silvia, Novello, Alessandra, Bearz, Pilar, Garrido, Julien, Mazieres, Alessandro, Morabito, Huamao M, Lin, Hui, Yang, Huifeng, Niu, Pingkuan, Zhang, Edward S, Kim
Publikováno v:
Scientia
Circulating tumor DNA; Non–small cell lung cancer; Tumor biomarker ADN tumoral circulante; Cáncer de pulmón de células no pequeñas; Biomarcador tumoral ADN tumoral circulant; Càncer de pulmó de cèl·lules no petites; Biomarcador tumoral Intr
Autor:
Thomas John, Christian Grohé, Jonathan W. Goldman, Frances A. Shepherd, Filippo de Marinis, Terufumi Kato, Qun Wang, Wu-Chou Su, Jin Hyuk Choi, Virote Sriuranpong, Barbara Melotti, Mary J. Fidler, Jun Chen, Muna Albayaty, Marta Stachowiak, Sarah Taggart, Yi-Long Wu, Masahiro Tsuboi, Roy S. Herbst, Margarita Majem
Publikováno v:
Journal of Thoracic Oncology.
Autor:
Maria Carmela Piccirillo, Laura Bonanno, Marina Chiara Garassino, Giovanna Esposito, Claudio Dazzi, Luigi Cavanna, Marco Angelo Burgio, Francesco Rosetti, Simona Rizzato, Floriana Morgillo, Saverio Cinieri, Antonello Veccia, Maximilan Papi, Giuseppe Tonini, Vittorio Gebbia, Serena Ricciardi, Daniele Pozzessere, Alessandra Ferro, Claudia Proto, Raffaele Costanzo, Manolo D’Arcangelo, Manuela Proietto, Piera Gargiulo, Raimondo Di Liello, Laura Arenare, Filippo De Marinis, Lucio Crinò, Fortunato Ciardiello, Nicola Normanno, Ciro Gallo, Francesco Perrone, Cesare Gridelli, Alessandro Morabito
Publikováno v:
Journal of Thoracic Oncology. 17:1086-1097
Adding bevacizumab to erlotinib prolonged progression-free survival (PFS) of patients with EGFR-mutated advanced NSCLC in the Japanese JO25567 trial, but limited data were available in non-Asian patients. BEVERLY is an Italian, multicenter, randomize
Autor:
Konstantin Laktionov, Chong-Jen Yu, Kye Young Lee, Frances A. Shepherd, Roy S. Herbst, Filippo de Marinis, Yi-Long Wu, Zhijie Wang, Jonathan W. Goldman, Charuwan Akewanlop, Christian Grohé, Terufumi Kato, Thomas John, Huu Vinh Vu, Margarita Majem, Laura Bonanno, Ajlan Atasoy, Masahiro Tsuboi, Lingmin Zeng, Sang-We Kim, Shun Lu, Manuel Domine
Publikováno v:
Journal of Thoracic Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Introduction: Adjuvant chemotherapy is recommended in patients with resected stages II to IIIA (and select IB) NSCLC; however, recurrence rates are high. In the phase 3 ADAURA study (NCT02511106), osimertinib was found to have a clinically meaningful
Autor:
Sarah M. Paul, Filippo de Marinis, Rafal Dziadziuszko, David S. Shames, Shirish M. Gadgeel, Hye Ryun Kim, Todd Riehl, Natasha B. Leighl, Osvaldo Arén Frontera, Ernest Nadal, Mark Yan, Jorge Arturo Alatorre-Alexander, Daniel Shao-Weng Tan, Ji Youn Han, Maurice Pérol, Dae Ho Lee, Rajesh Patel, Simonetta Mocci, Zoe June Assaf, M. Mathisen, Erica B. Schleifman, Tony Mok, Solange Peters, Virote Sriuranpong, Gilberto de Castro Junior
Publikováno v:
Journal of Thoracic Oncology. 16:2040-2050
Introduction The Blood First Assay Screening Trial is an ongoing open-label, multicohort study, prospectively evaluating the relationship between blood-based next-generation sequencing (NGS) detection of actionable genetic alterations and activity of
Autor:
Filippo de Marinis, Jean-Yves Douillard, Diether Lambrechts, Suresh S. Ramalingam, Lucio Crinò, Egbert F. Smit, Cesare Gridelli, Emilio Bria, Frank Griesinger, Maurice Pérol, Fortunato Ciardiello
Publikováno v:
Journal of Thoracic Oncology, 11(7), 1153-1169. International Association for the Study of Lung Cancer
de Marinis, F, Bria, E, Ciardiello, F, Crino, L, Douillard, J Y, Griesinger, F, Lambrechts, D, Perol, M, Ramalingam, S S, Smit, E F & Gridelli, C 2016, ' International Experts Panel Meeting of the Italian Association of Thoracic Oncology on Antiangiogenetic Drugs for Non-Small Cell Lung Cancer: Realities and Hopes ', Journal of Thoracic Oncology, vol. 11, no. 7, pp. 1153-1169 . https://doi.org/10.1016/j.jtho.2016.03.015
de Marinis, F, Bria, E, Ciardiello, F, Crino, L, Douillard, J Y, Griesinger, F, Lambrechts, D, Perol, M, Ramalingam, S S, Smit, E F & Gridelli, C 2016, ' International Experts Panel Meeting of the Italian Association of Thoracic Oncology on Antiangiogenetic Drugs for Non-Small Cell Lung Cancer: Realities and Hopes ', Journal of Thoracic Oncology, vol. 11, no. 7, pp. 1153-1169 . https://doi.org/10.1016/j.jtho.2016.03.015
Angiogenesis, one of the hallmarks of cancer, occurs when new blood vessels feed malignant cells, providing oxygen and nutrients, promoting tumor growth, and allowing tumor cells to escape into the circulation, thus leading to metastases. To date, a
Autor:
Takashi Seto, Egbert F. Smit, Li Zhang, Thomas Schmelter, Filippo de Marinis, Yi-Long Wu, Carol Peña, Luis Paz-Ares, Erszébet Juhász, Osvaldo Rudy Aren, Silvia Novello, Heather A. Wakelee, Vera Hirsh, Yan Sun, Teng Jin Ong, James Chih-Hsin Yang, Tony Mok
Publikováno v:
Journal of Thoracic Oncology. 10(12):1745-1753
Introduction Sorafenib monotherapy has shown benefits in phase II trials as third-/fourth-line treatment in patients with non-small-cell lung cancer (NSCLC). Methods The phase III, multinational, double-blind, placebo-controlled Monotherapy admInistr
Autor:
Lorenzo Spaggiari, Patrick Maisonneuve, Piergiorgio Solli, Daniela Brambilla, Juliana Guarize, Monica Casiraghi, Francesco Petrella, Filippo de Marinis
Publikováno v:
Journal of Thoracic Oncology. 10(6):924-929
Background The role of extended pulmonary resection for lung metastases is still unclear, and little information is available in the literature. This study was performed to analyze the outcomes and prognostic factors of patients who underwent extende
Autor:
Belen San Antonio, Kumar Prabhash, Luis Paz-Ares, William J. John, Annamaria Zimmermann, Fiona H Blackhall, Jean-Louis Pujol, Carla Visseren-Grul, Cesare Gridelli, Nadia Chouaki, Filippo de Marinis, Michael Thomas, Frederique Bustin, Claude El Kouri
Publikováno v:
Journal of Thoracic Oncology. 9(7):991-997
Introduction:The PARAMOUNT Phase III trial showed that maintenance pemetrexed after pemetrexed plus cisplatin induction was well tolerated and effective for patients with advanced nonsquamous non–small-cell lung cancer. Approximately 17% of patient
Autor:
Libero Giuffreda, Martin Wolf, Vittorio Gebbia, Silvia Marsoni, Salah-Eddin Al-Batran, Antonio Rossi, Marcello Tiseo, Laura Dal Zotto, Filippo de Marinis, Akin Atmaca, Chiara D’ Antonio
Publikováno v:
Journal of Thoracic Oncology. 8:1091-1094
Background: In vitro data suggest that panobinostat (LBH589), a pan-deacetylase inhibitor, may add therapeutic benefit in the treatment of small-cell lung cancer (SCLC) with regression of tumors. Methods: This multicenter, nonrandomized phase 2 trial